Ardena provides comprehensive bioanalytical services supporting drug development from discovery through clinical trials. Our scientists deliver phase-appropriate, regulatory-ready data for both small and large molecules, enabling the advancement of precision medicines.
#Data-driven #Reliable #Regulatory-ready
expertise
Our expertise covers LC-MS/MS, ligand binding assays, flow cytometry, and qPCR. We support small molecules, biologics, oligonucleotides, and cell and gene therapies, including nanomedicines with mRNA or antisense oligos, as well as biomarker analysis for CNS and inflammatory targets.
Key Products or Services
We offer method development and validation, sample analysis with flexible 3–10-day reporting, and regulatory-ready documentation. Our flexible and responsive approach ensures reliable results with short lead times and the scientific depth your program demands.
Vous souhaitez en savoir plus?
Thomas Scullion, Ph.D.
VP Business Development, Bioanalytical Sciences
thomas.scullion@ardena.com
Member of
